StockData
Lantheus Holdings, Inc. logo

Lantheus Holdings, Inc. (LNTH) stock

LNTHNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3012% above fair value
$102.00+0.20 (+0.20%)

Close on Nov 18, 2026Market cap $6.66BP/E 24.7Yield –

Lantheus net income

Net income is the profit left for shareholders after every expense, interest and tax.

Lantheus's net income for the twelve months ending Jun 30, 2026 was $275.31M, up 1.6% year over year. For fiscal 2025 it was $233.56M, down 25.2% from the year before. The highest annual figure on record is $326.66M in fiscal 2023.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$233.56M-25.2%
FY2024Dec 31, 2024$312.44M-4.4%
FY2023Dec 31, 2023$326.66M+1063.9%
FY2022Dec 31, 2022$28.07M–
FY2021Dec 31, 2021-$71.28M–
FY2020Dec 31, 2020-$13.47M-142.5%
FY2019Dec 31, 2019$31.67M-21.8%
FY2018Dec 31, 2018$40.52M-67.2%
FY2017Dec 31, 2017$123.39M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$75.03M-4.7%
Q1 FY2026Mar 31, 2026$118.42M+62.3%
Q4 FY2025Dec 31, 2025$54.09M–
Q3 FY2025Sep 30, 2025$27.77M-78.8%
Q2 FY2025Jun 30, 2025$78.76M+26.9%
Q1 FY2025Mar 31, 2025$72.95M-44.3%
Q4 FY2024Dec 31, 2024-$11.79M-111.4%
Q3 FY2024Sep 30, 2024$131.09M-0.7%
Q2 FY2024Jun 30, 2024$62.07M-34.1%
Q1 FY2024Mar 31, 2024$131.07M–
Q4 FY2023Dec 31, 2023$103.38M–
Q3 FY2023Sep 30, 2023$131.96M+115.5%
Q2 FY2023Jun 30, 2023$94.13M+118.6%
Q1 FY2023Mar 31, 2023-$2.81M-106.5%
Q4 FY2022Dec 31, 2022-$119.19M–
Q3 FY2022Sep 30, 2022$61.23M–
Q2 FY2022Jun 30, 2022$43.06M–
Q1 FY2022Mar 31, 2022$42.96M+376.9%
Q4 FY2021Dec 31, 2021-$40.22M–
Q3 FY2021Sep 30, 2021-$13.42M–
Q2 FY2021Jun 30, 2021-$26.66M–
Q1 FY2021Mar 31, 2021$9.01M+169.9%
Q4 FY2020Dec 31, 2020-$3.41M-132.7%
Q3 FY2020Sep 30, 2020-$6.39M-231.5%
Q2 FY2020Jun 30, 2020-$7.01M-209.4%
Q1 FY2020Mar 31, 2020$3.34M-66.5%
Q4 FY2019Dec 31, 2019$10.45M-21.4%
Q3 FY2019Sep 30, 2019$4.86M-47.6%
Q2 FY2019Jun 30, 2019$6.41M-34.2%
Q1 FY2019Mar 31, 2019$9.95M+21.2%
Q4 FY2018Dec 31, 2018$13.29M-86.3%
Q3 FY2018Sep 30, 2018$9.27M+8.7%
Q2 FY2018Jun 30, 2018$9.75M-28.3%
Q1 FY2018Mar 31, 2018$8.21M+98.4%
Q4 FY2017Dec 31, 2017$97.13M+1894.8%
Q3 FY2017Sep 30, 2017$8.53M+102.0%
Q2 FY2017Jun 30, 2017$13.60M–
Q1 FY2017Mar 31, 2017$4.14M–
Q4 FY2016Dec 31, 2016$4.87M–
Q3 FY2016Sep 30, 2016$4.22M–

More Lantheus figures

See a number that looks wrong?